ZNF574

gene
On this page

Also known as FLJ22059

Summary

ZNF574 (zinc finger protein 574, HGNC:26166) is a protein-coding gene on chromosome 19q13.2, encoding Zinc finger protein 574 (Q6ZN55). Part of a ribosome quality control that mediates surveillance of ribosome assembly and promotes degradation of ribosomes with assembly defects. It is a selective cancer dependency (DepMap: 72.0% of cell lines).

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 64763 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 142 total
  • Cancer dependency (DepMap): dependent in 72.0% of screened cell lines
  • MANE Select transcript: NM_022752

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26166
Approved symbolZNF574
Namezinc finger protein 574
Location19q13.2
Locus typegene with protein product
StatusApproved
AliasesFLJ22059
Ensembl geneENSG00000105732
Ensembl biotypeprotein_coding
Entrez64763

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 7 protein_coding

ENST00000222339, ENST00000359044, ENST00000597391, ENST00000600245, ENST00000852237, ENST00000933758, ENST00000933761

RefSeq mRNA: 2 — MANE Select: NM_022752 NM_001330519, NM_022752

CCDS: CCDS12596, CCDS82356

Canonical transcript exons

ENST00000359044 — 2 exons

ExonStartEnd
ENSE000015103054207616642076286
ENSE000030469524207858742081552

Expression profiles

Bgee: expression breadth ubiquitous, 277 present calls, max score 91.46.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.2892 / max 87.0869, expressed in 1797 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
17611213.28921797

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
type B pancreatic cellCL:000016991.46gold quality
olfactory bulbUBERON:000226491.38gold quality
cerebellar vermisUBERON:000472089.84gold quality
right testisUBERON:000453489.29gold quality
left testisUBERON:000453389.09gold quality
oocyteCL:000002389.08gold quality
vena cavaUBERON:000408789.06gold quality
tongue squamous epitheliumUBERON:000691988.16silver quality
parotid glandUBERON:000183187.70gold quality
testisUBERON:000047387.28gold quality
tendon of biceps brachiiUBERON:000818886.94silver quality
lateral nuclear group of thalamusUBERON:000273686.53gold quality
cervix squamous epitheliumUBERON:000692286.14silver quality
nippleUBERON:000203085.68gold quality
body of tongueUBERON:001187685.60gold quality
secondary oocyteCL:000065585.55gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.51gold quality
inferior olivary complexUBERON:000212785.49gold quality
nasal cavity epitheliumUBERON:000538485.31gold quality
male germ cellCL:000001585.22gold quality
dorsal motor nucleus of vagus nerveUBERON:000287085.04gold quality
dorsal plus ventral thalamusUBERON:000189784.74gold quality
spermCL:000001984.47gold quality
subthalamic nucleusUBERON:000190684.47gold quality
cardia of stomachUBERON:000116284.32silver quality
tongueUBERON:000172384.07gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451184.07gold quality
vastus lateralisUBERON:000137983.58silver quality
pharyngeal mucosaUBERON:000035583.05gold quality
heart right ventricleUBERON:000208082.97gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.78

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA1982.1ZNF574Factors with multiple dispersed zinc fingers
MA1982.2ZNF574Factors with multiple dispersed zinc fingers

JASPAR matrix evidence (PMIDs): PMID:22955616

miRNA regulators (miRDB)

18 targeting ZNF574, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-153-5P99.8973.866317
HSA-LET-7A-2-3P99.8770.531921
HSA-LET-7G-3P99.8570.431929
HSA-MIR-4639-5P99.8167.371028
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-182599.7268.111089
HSA-MIR-29B-2-5P99.6768.981726
HSA-MIR-320299.6667.702737
HSA-MIR-613499.6365.681537
HSA-MIR-312399.4767.152693
HSA-MIR-568399.3668.592083
HSA-MIR-429199.2068.882969
HSA-MIR-62298.9966.481050
HSA-MIR-1211498.7063.45730
HSA-MIR-3085-5P97.7265.43544
HSA-MIR-9851-5P97.5767.491067
HSA-MIR-426496.3564.761480
HSA-MIR-6777-3P95.3564.30699

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 72.0% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 1)

  • ZNF574 Promotes Ovarian Cancer Cell Proliferation and Migration through Regulating AKT and AMPK Signaling Pathways. (PMID:36197766)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriozgc:66472ENSDARG00000075916
mus_musculusZfp574ENSMUSG00000045252
rattus_norvegicusZfp574ENSRNOG00000055761
drosophila_melanogastermldFBGN0263490

Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)

Protein

Protein identifiers

Zinc finger protein 574Q6ZN55 (reviewed: Q6ZN55)

All UniProt accessions (3): Q6ZN55, A0A0C4DFM2, M0R133

UniProt curated annotations — full annotation on UniProt →

Function. Part of a ribosome quality control that mediates surveillance of ribosome assembly and promotes degradation of ribosomes with assembly defects.

Subunit / interactions. Associates with defective pre-ribosomes.

Subcellular location. Cytoplasm. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZN55-11yes
Q6ZN55-22

RefSeq proteins (2): NP_001317448, NP_073589* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050636C2H2-ZF_domain-containingFamily

Pfam: PF00096, PF12874, PF13912

UniProt features (40 total): zinc finger region 20, modified residue 7, region of interest 3, compositionally biased region 3, sequence variant 3, sequence conflict 2, chain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZN55-F163.540.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (7): 113, 164, 298, 717, 724, 728, 832

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 114 (showing top): GOBP_RIBOSOME_BIOGENESIS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_RIBOSOME_ASSEMBLY, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, MARTINEZ_RB1_TARGETS_UP, MARTINEZ_RB1_TARGETS_DN, GOBP_ORGANELLE_ASSEMBLY, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEOLYSIS, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RIBOSOME_BINDING

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), developmental process (GO:0032502)

GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
biological_process1
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

892 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF574TMEM145Q8NBT3582
ZNF574CNFNQ9BYD5549
ZNF574CEACAM7Q14002526
ZNF574PAFAH1B3Q15102525
ZNF574MANBALQ9NQG1490
ZNF574PLEKHJ1Q9NW61477
ZNF574TRMT1LQ7Z2T5451
ZNF574PRR19A6NJB7447
ZNF574TRMT10AQ8TBZ6433
ZNF574PSG11Q9UQ72411
ZNF574ZNF512Q96ME7407
ZNF574PSG6Q00889405
ZNF574NAA38Q9BRA0396
ZNF574PSG4Q00888392
ZNF574PSG1P11462391
ZNF574TOMM40LQ969M1391

IntAct

95 interactions, top by confidence:

ABTypeScore
LARP7CCNT1psi-mi:“MI:0914”(association)0.850
GPR156PLD2psi-mi:“MI:0914”(association)0.640
LIN28AIGF2BP3psi-mi:“MI:0914”(association)0.640
THAP12ZNF574psi-mi:“MI:0915”(physical association)0.620
ZNF574THAP12psi-mi:“MI:0914”(association)0.620
NNOP56psi-mi:“MI:0914”(association)0.530
RPS3ZNF316psi-mi:“MI:0914”(association)0.530
MAGEB2POLRMTpsi-mi:“MI:0914”(association)0.530
ZNF689ZNF593psi-mi:“MI:0914”(association)0.530
RPS2MPHOSPH10psi-mi:“MI:0914”(association)0.530
ZC3HAV1KHNYNpsi-mi:“MI:0914”(association)0.530
E4F1ZBTB24psi-mi:“MI:0914”(association)0.530
XAGE1ATHAP12psi-mi:“MI:0914”(association)0.530
NIFKRSL1D1psi-mi:“MI:0914”(association)0.530
RPSARPS17psi-mi:“MI:0914”(association)0.530
ABT1ZNF316psi-mi:“MI:0914”(association)0.530
MAGEB2GTPBP10psi-mi:“MI:0914”(association)0.530
ZNF574E2psi-mi:“MI:0915”(physical association)0.370
ZNF574E7psi-mi:“MI:0915”(physical association)0.370
ZNF526VAMP4psi-mi:“MI:0914”(association)0.350
SetZKSCAN1psi-mi:“MI:0914”(association)0.350
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
rl3_rl3l_humanNKRFpsi-mi:“MI:0914”(association)0.350
rl36a_rl36l_humanIPO5psi-mi:“MI:0914”(association)0.350
IGHMESYT2psi-mi:“MI:0914”(association)0.350
RPS19ZNF320psi-mi:“MI:0914”(association)0.350
PURGZNF320psi-mi:“MI:0914”(association)0.350
ZNF467ZNF320psi-mi:“MI:0914”(association)0.350

BioGRID (301): ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Reconstituted Complex), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), ZNF574 (Affinity Capture-MS), SHCBP1 (Affinity Capture-MS), PRKRIR (Affinity Capture-MS), TRIM41 (Affinity Capture-MS), ANKRD28 (Affinity Capture-MS)

ESM2 similar proteins: A2A5K6, A6QR00, D4A8X0, E9Q6W4, G3V893, O15015, O15156, O95863, P0CJ78, P10074, Q02085, Q13105, Q29RK0, Q3U3I9, Q4R8S8, Q504L7, Q5EBL2, Q5F293, Q5R4P8, Q5RJR4, Q60821, Q66K89, Q6DD87, Q6GL52, Q6NV66, Q6PGE4, Q6YND2, Q6ZN55, Q80VM4, Q8BI66, Q8BI69, Q8BIF9, Q8BY46, Q8CCE9, Q8CJ78, Q8JZL0, Q8N1W2, Q8NCA9, Q8TF50, Q8WUU4

Diamond homologs: A1L2U9, A2A884, A2ANX9, A7Y7X5, B0X9H6, B0YDH7, B1WAZ8, B1WBU4, E9PW05, E9PZZ1, G5EBU4, O15391, O60315, O62836, O75362, O77459, O95863, P08048, P0CS62, P0CS63, P10925, P15822, P17010, P17012, P20662, P22227, P25490, P28166, P31509, P31629, P36197, P52739, P52746, P56270, P56670, P56671, P60319, P80944, Q00899, Q00900

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 106 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
SARS-CoV-1 modulates host translation machinery1053.2×4e-14
Eukaryotic Translation Initiation947.9×2e-12
Cap-dependent Translation Initiation947.9×2e-12
Eukaryotic Translation Elongation943.2×4e-12
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S942.2×5e-12
Influenza Viral RNA Transcription and Replication1037.1×1e-12
Nonsense-Mediated Decay (NMD)936.2×2e-11
SARS-CoV-2 modulates host translation machinery934.8×3e-11

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation1428.8×2e-14
ribosomal small subunit biogenesis1025.3×8e-10
regulation of alternative mRNA splicing, via spliceosome821.7×3e-07
rRNA processing1117.3×4e-09
translation1314.8×8e-10
RNA splicing76.9×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

142 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance137
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

468 predictions. Top by Δscore:

VariantEffectΔscore
19:42078585:A:AGacceptor_gain1.0000
19:42078586:G:GAacceptor_gain1.0000
19:42078586:GC:Gacceptor_gain1.0000
19:42078586:GCCC:Gacceptor_gain1.0000
19:42078586:GCCCA:Gacceptor_gain1.0000
19:42078572:T:Aacceptor_gain0.9900
19:42078586:GCC:Gacceptor_gain0.9900
19:42070967:C:Tdonor_gain0.9700
19:42078570:ACT:Aacceptor_gain0.9600
19:42078571:C:Gacceptor_gain0.9600
19:42070905:G:GTdonor_gain0.9500
19:42070803:A:Gdonor_gain0.9400
19:42070939:C:Tdonor_gain0.9300
19:42076129:G:GTdonor_gain0.9300
19:42078570:A:AGacceptor_gain0.9300
19:42070789:A:Tdonor_gain0.9200
19:42076130:A:Tdonor_gain0.9200
19:42070869:G:GTdonor_gain0.9100
19:42070870:G:Tdonor_gain0.9100
19:42078581:TTCCA:Tacceptor_gain0.9000
19:42078582:TCCAG:Tacceptor_gain0.9000
19:42078583:CCAGC:Cacceptor_gain0.9000
19:42078584:CAGC:Cacceptor_gain0.9000
19:42078585:A:Cacceptor_gain0.9000
19:42078586:G:Tacceptor_gain0.9000
19:42076282:AGCAG:Adonor_loss0.8800
19:42076284:CAGGT:Cdonor_loss0.8800
19:42076285:AGG:Adonor_loss0.8800
19:42076286:GG:Gdonor_loss0.8800
19:42076287:GTGAG:Gdonor_loss0.8800

AlphaMissense

5740 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:42080179:T:CC525R1.000
19:42080284:T:CF560L1.000
19:42080285:T:CF560S1.000
19:42080286:C:AF560L1.000
19:42080286:C:GF560L1.000
19:42080908:T:CC768R1.000
19:42080929:T:CF775L1.000
19:42080931:C:AF775L1.000
19:42080931:C:GF775L1.000
19:42081013:T:CF803L1.000
19:42081014:T:CF803S1.000
19:42081015:T:AF803L1.000
19:42081015:T:GF803L1.000
19:42081076:T:CC824R1.000
19:42078988:T:CC128R0.999
19:42079009:T:CF135L0.999
19:42079010:T:CF135S0.999
19:42079011:T:AF135L0.999
19:42079011:T:GF135L0.999
19:42079274:T:CF223S0.999
19:42079618:T:CC338R0.999
19:42079786:T:CC394R0.999
19:42079804:T:CF400L0.999
19:42079806:T:AF400L0.999
19:42079806:T:GF400L0.999
19:42080008:T:CC468R0.999
19:42080095:T:CC497R0.999
19:42080181:C:GC525W0.999
19:42080188:T:CC528R0.999
19:42080190:C:GC528W0.999

dbSNP variants (sampled 300 via entrez): RS1000238800 (19:42068839 G>A), RS1000480941 (19:42081351 A>G), RS1000571702 (19:42069746 G>A,T), RS1000800980 (19:42075327 G>A), RS1000853440 (19:42075577 G>T), RS1000904965 (19:42075167 G>A,C), RS1001063205 (19:42069325 G>A,T), RS1001220306 (19:42066526 G>A), RS1001315755 (19:42074448 C>T), RS1001410872 (19:42069148 G>A,T), RS1001475908 (19:42077949 G>A), RS1001504705 (19:42069498 G>A), RS1001529736 (19:42078276 G>A,T), RS1001740574 (19:42071791 G>A), RS1001807824 (19:42076464 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010143_27Meat-related diet3.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0008111diet measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
FR900359decreases phosphorylation1
TAK-243increases sumoylation1
sodium arsenitedecreases expression1
potassium chromate(VI)increases expression, affects cotreatment1
epigallocatechin gallateaffects cotreatment, increases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
abrineincreases expression1
PCI 5002increases expression, affects cotreatment1
Irinotecandecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Diurondecreases expression1
Doxorubicindecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Potassium Chloridedecreases response to substance, increases expression1
Smokedecreases expression1
Dronabinolincreases expression, decreases response to substance1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidincreases methylation1
Zincaffects cotreatment, increases expression1
Cyclosporineincreases expression1
Antirheumatic Agentsincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.